Mr. Hans Ivar Robinson joined the board of Nextera in 2010 (board member) and has since 2012 had the role as chairman. Hans Ivar is the founder and managing director of Birk Venture and is currently holding several board positions in biotech companies. Mr. Robinson has 20 years professional experience in the Pharmaceutical and Biotech industry. He has held several leading international positions in AstraZeneca, Pfizer and Pronova BioPharma.
His experience covers a broad specter within the pharmaceutical and biotech industry. This includes top management, marketing, sales, business development, licensing, regulatory affairs and product life cycle management. His background includes a broad international network in several pharmaceutical and biotech companies in Europe, US and key emerging markets. He has experience working with investors and the financial community including the IPO listing of Pronova BioPharma in 2007. Mr. Robinson holds an MSc from Norwegian School of Economics (NHH).